...
首页> 外文期刊>Water Environment Research >Optimization of Coagulation with PFS-PDADMAC Composite Coagulants Using the Response Surface Methodology Experimental Design Technique
【24h】

Optimization of Coagulation with PFS-PDADMAC Composite Coagulants Using the Response Surface Methodology Experimental Design Technique

机译:响应面法实验设计技术优化PFS-PDADMAC复合混凝剂的混凝

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, two composite coagulants, PFPD_1, and PFPD_2, were prepared and studied with the inorganic polymer coagulant PFS. A response surface design was used to investigate the effect that changes in the level of coagulant dose and coagulation pH have on residual turbidity and TOC. In addition, the optimum combinations of dose and pH, that yield the lowest residual turbidity and TOC, were determined. The results revealed that the Optimum conditions for the three coagulants were a dosage of 204 mg/L and pH of 8.06 for PFS; a dosage of 179 mg/L and pH of 7.99 for PFPD_1; and a dosage of 112 mg/L and pH of 7.65 for PFPD_2. The models showed that for residual turbidity, the effectiveness of the coagulants in decreasing order was PFS>PFPD_1>PFPD_2, while for residual TOC, the order was PFPD_2>PFPD_1>PFS. The verification experiments demonstrated that a RSM approach was appropriate for optimizing the coagulation-flocculation process.
机译:在这项研究中,制备了两种复合凝结剂PFPD_1和PFPD_2,并用无机聚合物凝结剂PFS进行了研究。响应面设计用于研究凝结剂剂量水平和凝结pH值变化对残留浊度和TOC的影响。此外,确定了产生最低残留浊度和TOC的最佳剂量和pH组合。结果表明,三种凝结剂的最佳条件是:PFS的剂量为204 mg / L,pH值为8.06。 PFPD_1的剂量为179 mg / L,pH为7.99; PFPD_2的剂量为112 mg / L,pH为7.65。模型显示,对于残留浊度,凝结剂的降序排列顺序为:PFS> PFPD_1> PFPD_2,而对于残留TOC,凝结剂的排列顺序为:PFPD_2> PFPD_1> PFS。验证实验表明,RSM方法适用于优化混凝过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号